MK

Maruthappa Kogali Amaravathi

Active Director Director DIN 11090483
DIN 11090483 First appointment May 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Maruthappa Kogali Amaravathi

Data last updated:

Maruthappa Kogali Amaravathi is a Director at Suchikitsa Hospitals Private Limited (since 2025). The company operates in Healthcare.

DIN 11090483
Primary Designation Director
Industry Healthcare
First Appointment 05 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Suchikitsa Hospitals Private Limited U86100KA2025PTC202343
Director05 May 20252025Active

Board colleagues of Maruthappa Kogali Amaravathi

Directorship timeline

Open interactive timeline →
Suchikitsa Hospitals Private Limited
Premium access

Shareholding and investment profile for Maruthappa Kogali Amaravathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maruthappa Kogali Amaravathi

Maruthappa Kogali Amaravathi currently holds 1 directorship: Suchikitsa Hospitals Private Limited (Director, since 05 May 2025).

Maruthappa Kogali Amaravathi was first appointed on 05 May 2025 as Director at Suchikitsa Hospitals Private Limited.

The current boards of Maruthappa Kogali Amaravathi's companies include Mukunda Naidu Ganaparthi (Suchikitsa Hospitals Private Limited), Sukesh Shetty (Suchikitsa Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available